Recognizing the importance of a coordinated approach, UTHealth has convened a university-wide task force to help steer the university’s response on COVID-19 research. The pandemic has resulted in research interest throughout the world with substantial funding opportunities. Charles “Trey” Miller, PhD, associate dean for hospital quality initiatives, director of the Center for Clinical Research and […]
A drug purified and developed from the sap of a tree in the Amazon rainforest is now being studied for the treatment of chronic idiopathic diarrhea in non-HIV patients by faculty in the Division of Gastroenterology, Hepatology and Nutrition as part of a two-year pilot study. The novel drug, crofelemer, comes from the Croton lechleri […]
The National Institute of Health has awarded a pair of grants to Cynthia Ju, PhD, Roy M. and Phyllis Gough Huffington Distinguished Professor and Joseph C. Gabel, MD, Chair in Anesthesiology, to find therapeutic targets for hepatic ischemia and reperfusion injury and overdose acetaminophen (Tylenol)-induced liver injury.
A discovery by cancer biologists at McGovern Medical School helps explain how prostate cancer eventually develops resistance to a leading treatment and becomes lethal.
In 2015, the United Nations designated Feb. 11 as International Day of Women and Girls in Science to encourage gender equality in the sciences. On Feb. 11 this year, McGovern Medical School will celebrate this international day with a special symposium.
The Department of Psychiatry and Behavioral Sciences at McGovern Medical School invites mental health clinicians, geriatricians, nurses, social workers, and other caregivers of older adults to the 10th Annual Psychiatry Update: New Horizons in Geriatric Psychiatry Feb. 2 at Memorial Hermann-Texas Medical Center (6411 Fannin).
Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from McGovern Medical School.
An inaugural clinical trial that uses gold nanoparticles as tumor-seeking missiles to remove prostate cancer is underway at McGovern Medical School.
Do you have a cancer-related research project and are interested in hosting an exceptional undergraduate with a young innovative mind from June 3 –Aug. 9, 2019?